51视频

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 51视频 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • 51视频

    51视频

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 21 2021

Full Issue

Different Takes: Lessons On How To Protect The Most Americans; Restore Travel Restrictions Because Of Variants

Editorial pages focus on these pandemic topics and others.

This combination of lasting immunity and effective vaccines has been the cornerstone of almost all past successes against viruses (HIV, to date, being the key exception). It鈥檚 how the scourges of smallpox, polio, measles, mumps, and other infectious diseases have been beaten. And it鈥檚 how we are going to beat Covid-19.But even in a best-case scenario, it will be months before enough vaccine doses have been made to treat everyone. With epidemiologists estimating that two-thirds of the population must be immune for the herd protection needed to quell the pandemic, an antibody-assisted approach would let us reach that threshold faster. (Michael Rose, 1/21)

Last week, as friends of mine learned they would soon be eligible for a Covid-19 vaccination, I received a slew of angst-ridden text messages. A teacher who sees students only once a week wondered if she should wait so teachers who were more at risk could get a shot first. A friend with a health condition who is mostly able to stay home and isolate pondered letting her dose go to someone more deserving. On social media, I stumbled across posts from friends who are eligible for vaccination but could not get appointments 鈥� and who were angry that others they knew, whom they considered lower risk, had already been inoculated. As more and more Americans become eligible for Covid-19 vaccines despite their limited supply, deciding whether to take an available shot has turned into a moral quandary. There鈥檚 no question that vaccine access has been inequitable across parts of the country. But many medical ethicists agree: If you are eligible for a vaccination, you should get it, no matter how worthy 鈥� or unworthy 鈥� you feel. (Melinda Wenner Moyer, 1/21)

The urgent text from a friend came late Friday afternoon: If you want to get the COVID-19 vaccine, go immediately to the website for the UC Irvine healthcare system and schedule an appointment. I didn鈥檛 wait to ask questions. I clicked the link she sent me and, amazingly enough, it looked as though there were plenty of open spaces each morning throughout the holiday weekend. I picked Monday.Lucky me. The question is, why me? The answer is heart-sinking: Because of disorganized policies at the state level and confusion in the counties. Health authorities are looking to get people vaccinated quickly, a good thing, but that鈥檚 resulted in sloppiness and a lack of clarity as officials have set priorities and communicated with the public. (Karin Klein, 1/20)

After what feels like the longest year in any adult life, it finally looked as if covid-19 was about to be over. All the old disputes about whether to restrict our lives while we waited for a vaccine or just go about our lives to reach herd immunity naturally had been mooted by the lightning-fast production of two good vaccines. It appears the viruses of South Africa would like a word with us. (Megan McArdle, 1/20)

When I saw Bill Clinton鈥檚 mask slip below his nose during the inaugural festivities, I figured, well, it could happen to any of us. But then John Roberts鈥檚 mask was not entirely covering his nose at different points. And even Barack Obama鈥檚 mask dipped below the tip of his nose at one point. A couple months back, then-President Trump鈥檚 economic adviser Larry Kudlow was spotted outside the West Wing with his mask down. I realized it鈥檚 not a Democratic thing. Or a Republican thing. Or an inaugural thing. It鈥檚 a male thing. It鈥檚 like manspreading, but with masks. Call it manslipping.(James Gorman, 1/20)

That effective vaccines are now being rolled out, albeit not as quickly as needed, and that Wednesday saw the inauguration of a president who has promised a plan of action against the pandemic are reasons for some hope. It is important, though, that we never forget the precious lives lost and how many could have been saved if government had not failed. (1/20)

Thursday, the nation will wake up and there will be no tweet from the president of the United States fomenting ignorance and division, encouraging people to act outrageously or to disbelieve science. He won鈥檛 be wondering aloud whether bleach, taken internally, would prevent or cure COVID-19. He won鈥檛 make a new enemy of another longtime ally or enact a sudden travel ban against predominantly Muslim countries that separates families and strands travelers at airports with visas in hand. (1/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, October 2
  • Thursday, October 1
  • Wednesday, September 30
  • Tuesday, September 29
  • Monday, September 28
  • Friday, September 25
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • 51视频
  • Privacy Policy

漏 2026 51视频